U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
REMTOLUMAB
INN   WHO-DD  
INN  
Official Name English
A-1230717
Preferred Name English
remtolumab [INN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL17A (INTERLEUKIN 17A, IL-17A) AND HOMO SAPIENS TNF (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 2, TNFSF2, TNF-ALPHA, TNFA)), HOMO SAPIENS MONOCLONAL ANTIBODY, TETRAVALENT BISPECIFIC GAMMA1 HEAVY CHAIN (1-
Systematic Name English
Remtolumab [WHO-DD]
Common Name English
ABT-122
Code English
IMMUNOGLOBULIN, ANTI-(TUMOR NECROSIS FACTOR .ALPHA./INTERLEUKIN 17) (SYNTHETIC HUMAN A-1230717 HEAVY CHAIN), DISULFIDE WITH SYNTHETIC HUMAN A-1230717 LIGHT CHAIN, DIMER
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
NCI_THESAURUS C1454
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
Code System Code Type Description
INN
10345
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
PRIMARY
NCI_THESAURUS
C152189
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
PRIMARY
SMS_ID
100000173003
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
PRIMARY
CAS
1791410-27-9
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
PRIMARY
DRUG BANK
DB15128
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
PRIMARY
IUPHAR
9597
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
PRIMARY
FDA UNII
1V8WRH3RVX
Created by admin on Tue Apr 01 16:40:56 GMT 2025 , Edited by admin on Tue Apr 01 16:40:56 GMT 2025
PRIMARY
ACTIVE MOIETY
REMTOLUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966